NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs031180292

Registered date:15/03/2019

Fibrinolytic therapy with urokinase

Basic Information

Recruitment status Complete
Health condition(s) or Problem(s) studiedRefractory intrathoracic infection
Date of first enrollment19/10/2018
Target sample size30
Countries of recruitment
Study typeInterventional
Intervention(s)Intrapleural injection of 60,000 to 120,000 units of urokinase per day. Injection 1 to 3 days.

Outcome(s)

Primary OutcomeRatio of patients that were cured without surgical intervention during hospitalization
Secondary OutcomeRatio of serious adverse events

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderBoth
Include criteria1.Patient with refractory intrathoracic infection 2. Patient with thoracic drain 3. Hospitalized patient 4. Patient with consent
Exclude criteria1.Patient with active intrathoracic bleeding 2. Patients considered unfit to participate by a doctor

Related Information

Contact

Public contact
Name Seshiru Nakazawa
Address 3-39-15 Showa-machi, Maebashi, Gunma,JAPAN Gunma Japan 371-8511
Telephone +81-27-220-8224
E-mail snakazawa@gunma-u.ac.jp
Affiliation Gunma University Hospital
Scientific contact
Name Toshiki Yajima
Address 3-39-15 Showa-machi, Maebashi, Gunma,JAPAN Gunma Japan 371-8511
Telephone +81-27-220-8224
E-mail yajimato@gunma-u.ac.jp
Affiliation Gunma University Hospital